Therabel Pharma N.V.
Industry
- Pharmaceuticals
- OTC, Consumer
- Specialty Pharmaceuticals
See more in Biomedtracker
Latest on Therabel Pharma N.V.
In Vivo
• By Amanda Micklus
When a drug developer loses a partner, there's actually a 50-50 chance that the drug will remain in development, according to a new study of deals data from Informa’s Strategic Transactions . And of
Scrip
• By Pial Ganguli
BioAlliance Pharma has entered into a licence agreement with Vestiq Pharmaceuticals, under which the latter gains the US commercialisation rights to the antifungal treatment, Oravig (miconazole), for
Scrip
• By Francesca Bruce
The Scottish Medicines Consortium (SMC), Scotland's health technology assessment body, has recommended Roche's Mabthera (rituximab) as a maintenance therapy for treating follicular lymphoma after indu